Package 51079-917-20

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51079-917-20
Digits Only 5107991720
Product NDC 51079-917
Description

100 BLISTER PACK in 1 CARTON (51079-917-20) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-917-01)

Marketing

Marketing Status
Marketed Since 1999-10-01
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3a87770c-fa53-d061-e063-6294a90a6751", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897612"], "spl_set_id": ["3bee2d26-138c-4641-a217-a38d3d657461"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (51079-917-20)  / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-917-01)", "package_ndc": "51079-917-20", "marketing_start_date": "19991001"}], "brand_name": "Verapamil Hydrochloride", "product_id": "51079-917_3a87770c-fa53-d061-e063-6294a90a6751", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51079-917", "generic_name": "verapamil hydrochloride", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA075138", "marketing_category": "ANDA", "marketing_start_date": "19991001", "listing_expiration_date": "20261231"}